[Headlines Only] [Top Stories Only]
Categories
· Cessation
· Zyban

• U.S. generic competition nears on Glaxo drugs 

Jump to full article: Reuters, 2003-07-31
Author: (Recasts, adds details throughout)

Intro:

Two drugmakers on Thursday moved closer to marketing their generic versions of profitable GlaxoSmithKline Plc (GSK.L) (NYSE:GSK) drugs, dealing blows that sent shares of the world's second-largest drugmaker lower. . . .

And Impax Laboratories Inc. (Nasdaq:IPXL) signed a deal with Andrx Corp. (Nasdaq:ADRX) that would allow Impax to market its generic versions of antidepressant Wellbutrin SR and smoking cessation drug Zyban even if Andrx got approval for its copycats before Impax did.

Jump to full article »